Background: Obstructive sleep apnea (OSA) is defined as a sleep disorder marked by pauses in breathing of 10 seconds or more causing unrestful sleep and accompanied by loud or abnormal snoring, daytime sleepiness, irritability, and depression. According to the National Sleep Foundation, more than 18 million Americans have OSA, 80% of whom are undiagnosed. The [...]

Background: In the outpatient setting, untreated obstructive sleep apnea (OSA) is associated with myriad adverse clinical outcomes including myocardial infarction, heart failure, arrhythmias, and cerebrovascular disease.  However, little is known about the impact of treated versus untreated OSA on short-term outcomes in patients hospitalized with acute illness. We propose that the recurrent hypopnea and apnea [...]

Background: Obstructive sleep apnea (OSA) is closely associated with obesity, and weight reduction is a critical component of its management. Glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) agonists have shown promise in promoting weight loss, potentially improving outcomes in OSA patients. We aimed to calculate the mean reduction in BMI and waist circumference after [...]

Case Presentation: A 16 y/o male presented with an acute onset of palpitations, generalized chest pain, and rash (Figure 1). In light of recent camping exposure and targetoid lesions compatible with erythema chronicum migrans (ECM), Lyme disease was suspected. An EKG demonstrated 1st degree AV block with a PR interval of 384 msec. Echocardiogram and [...]